chrisvoncsefalvay/vaers-outcomes huggingface dataset:
maternal exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (maternal exposure during pregnancy) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032L20A and 012A21A) for COVID-19 vaccination.     Concomitant products included SERTRALINE and MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for an unknown indication.   On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on 19-Jan-2021 and the estimated date of delivery was 26-Oct-2021. On 25-Feb-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (maternal exposure during pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) during pregnancy.  On 25-Feb-2021, MATERNAL EXPOSURE DURING PREGNANCY (maternal exposure during pregnancy) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-Feb-2021, Pregnancy test: positive (Positive) positive.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The estimated date of conception was reported as 06-Jan-2021. The patient had no maternal history of subfertility and had established prenatal care. There was no complications or acute illness reported during tis pregnancy. Number of fetuses was reported as 1.
The day after receiving my vaccine I woke up tired, body aches, chills, upset stomach all day. The next day I was fine.
3/13/21 Red rash on neck   3/23/21 Rash Worse  3/31/21 Rash Worse and Spreading  4/16/21 Rash Head to Thighs, Peeling, Itching, Swollen Eyelids - diagnosed as Pityriasis Rubra Pilaris
The evening of the shot I had swelling and extreme discomfort and was unable to move my arm above horizontal. The selling subsided however the pain and inability to lift the arm continued in spite of taking 600 mg of ibuprofen three times per day and icing the area. On 10/24/ after still having no relief, I visited my PCP who advised me ti increase the ibuprofen to 800 mg tid and continue with ice and if still no relief prescribed a medrol dosepak. Upon completing the dosepak, still no relief so I have been referred to an orthopedic MD who has prescribed physical therapy, however advised pain could last up to 2 years
Lost taste; Lost sense of smell; Covid test positive; This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of AGEUSIA (Lost taste), ANOSMIA (Lost sense of smell) and SARS-COV-2 TEST POSITIVE (Covid test positive) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     Concurrent medical conditions included Coronavirus test positive (COVID-19) on 06-Jan-2021 and Cough.    On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 06-Jan-2021, the patient experienced AGEUSIA (Lost taste), ANOSMIA (Lost sense of smell) and SARS-COV-2 TEST POSITIVE (Covid test positive). At the time of the report, AGEUSIA (Lost taste), ANOSMIA (Lost sense of smell) and SARS-COV-2 TEST POSITIVE (Covid test positive) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-Jan-2021, SARS-CoV-2 test: (Positive) COVID-19.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Sender's Comment. This case concerns a 51-year-old male who experienced NS unexpected events of ageusia, anosmia and SARS-CoV-2 test positive. Event onset occurred Days 3 after the first dose of mRNA-1273. Treatment included dextromethorphan, doxylamine, acetaminophen, azithromycin. Event outcomes unknown. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.   Reporter did not allow further contact; Reporter's Comments: This case concerns a 51-year-old male who experienced NS unexpected events of ageusia, anosmia and SARS-CoV-2 test positive. Event onset occurred Days 3 after the first dose of mRNA-1273. Treatment included dextromethorphan, doxylamine, acetaminophen, azithromycin. Event outcomes unknown. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
I got vaccinated with second dose on April 2021, on the 3rd of April I started having severe head pain, and strong Tachycardia and my pressure increased. I still take medication for pressure and Tachycardia, both are under control. My arm has a red circular spot with the second dose.
Somewhere between half an hour and 45 min after my shot I developed a slight headache and intermittent moderate joint pain in my lower back and left  elbow.  The joint pain is there for a few seconds then it goes away. May be triggered by movement. Nothing wrong with my joints, nothing recent to stress it.
little specks on face and chest; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of MILIA (little specks on face and chest) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced MILIA (little specks on face and chest). At the time of the report, MILIA (little specks on face and chest) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. No treatment information was provided.   This case was linked to MOD-2021-100529 (Patient Link).
pt experienced sore arm and neck as well as sore throat for aboput 48 hours after shot
Patient got lightheaded after receiving the vaccine and he laided himself on the floor. Patient states that he gets this way all the time after getting shots and getting blood draw. Patient drank some water and is feeling better.
On Wednesday, October 28, 2009, I went to my local health department to get my H1N1 vaccine. Everything went well, or so I thought. The next day, October 29, 2009, I had an appointment with my OB/GYN for a regular check-up. We talked, laughed, etc. and before I left, the nurse practitioner told me she needed to do an ultrasound to hear the baby's heart rate before I could go home. I was 8 weeks pregnant, by the way, so the heart rate could not be heard on the doppler. Anyway, she did the abdominal ultrasound and could not find a heart rate. So, she did the transvaginal ultrasound just to make sure. We could see the baby and the baby was measuring 8 weeks, but there was no heart rate. This was a COMPLETE shock because I was not experiencing any spotting, cramping, etc. So, to say the least, I was totally devastated that I had lost my baby. On Friday, October 30, 2009, I had a suction D&C. I do not know if the H1N1 vaccine was the cause of the miscarriage, but I wanted to let you know that I did have a miscarriage after receiving the vaccine.  11/6/09:  Operative Report received for date of service 10/30/09:  Dx:  Missed abortion.   Assessment:  Suction Dilation and Curettage:  10 week size uterus.  Products of Conception were sent to pathology.  Less than 200 ml blood loss. 11/9/09:  Ob/GYN records received for dates of service 10/15/09 to 10/29/09:  Assessment:  No heart beat on doppler, no color flow.  Schedule for D & C.
Shot given on 1/29  Flu symptoms started on 2/5 Ambulance ER visit with Flu diagnosis and later Covid diagnosis on 2/10 but sent home 2/11-2/13 progressively worsened with high fever starting, unable to walk from weakness and trouble breathing with coughing Taken by ambulance to Hospital on 2/13 and admitted to ICU 2/15 put on vent 3/22 switched from ET tube to tracheostomy  3/23 moved from ICU to LTAC still not fully awake and coherent and still on vent as of 3/24/21
Fatigue. Temperature of 101.0. Took two Tylenol at 9pm and stay in bed. Some chills.
Patient received immunization evening of 21 January (1740). On awaking the next morning at 0700 mother noted edema to R face and swelling below eye.  She administered one dose of zyrtec. At time of exam at 1020 on 22 January, there was no residual facial edema, mild infraorbital edema under R eye.   The mother of the patient said his symptoms are similar to reactions he has had from environmental exposures in the past.
Neck was chocking I feel like that I have taken a pill and it stuck in a throat; My breaths starts to close in I couldn't breathe; I have a lot of trouble in breathing; I couldn't eat; I couldn't sleep; I was very dizzy; I had a lot of vomiting; I couldn't even swallow; My neck was really getting swollen; I had fever; Chills; This is a spontaneous report from a contactable consumer (patient). A 22-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: 5EW0182), via an unspecified route of administration on 03May2021 (at the age of 22-years-old) as a single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient reported that she got her shot right in, "my breaths starts to close in I couldn't breathe", "I couldn't eat", "I couldn't sleep", "I was very dizzy", "I had a lot of vomiting" and it was basically not good. Then she went to the urgent care because "I couldn't even swallow", "my neck was really getting swollen" and "neck was chocking I feel like that I have taken a pill and it stuck in a throat" and then "I had fever", chills and a lot of hard time. When paraphrased the above concern, the patient stated, and then "I have a lot of trouble in breathing". She received the second dose on 24May2021. The patient stated, the only thing that they gave her was Ibuprofen because they say, that's the only thing that they could give her. The outcome of all the events was unknown.  Follow-up attempts completed. No further information expected.
Extremely sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Extremely sore arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Extremely sore arm). At the time of the report, PAIN IN EXTREMITY (Extremely sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment information was not reported.
7 minutes after the injection of my Janssen injection for COVID-19, a heat enveloped my body from deep in my chest and I went pale (according to the objective findings of my nurse) and I began to feel lightheaded and almost became syncopal. I was asked to remain there for 30-minutes, and began to feel better shortly thereafter. The next several days, the lightheadedness came and went in waves, which became stronger and stronger. Two days post-injection, I developed severe joint pain where I'd otherwise previously had none - for instance, my low back ached with 7/10 pain which only went away after the first week. I had thoracic spinal pain which radiated to my chest, and by day 3 I was having serial panic attacks (which I don't have), such that I visited the local emergency department to rule out sinister cardiorespiratory sequelae. I was discharged with a ddx of GERD, though I do not believe this to be true. Since then, I have largely recovered, however the lightheaded spells have dissipated only a little but are largely still plaguing me. Thankfully, the panic attacks have decreased to the point of almost being gone altogether.
pt was given vax 950AM 145 mom said temp 104.6;mom gave Motrin & APAP 245; temp dec to 102;
After receiving the shot, later that night I started getting extremely sore and tired. Walking became more difficult. Within that week I had broken out with red dots all over my legs, the worst part being my ankles. I had problems with swelling around my ankles and knees and lower back. Walking was difficult and painful. I went back to the doctor and he informed me I had a hypersensitivity reaction (type 3), and prescribed me a steroid (MEDROL 4 MG Oral Tablet Therapy Pack - 4 MG). I took the steroid as prescribed. However, the symptoms have persisted. I am now seeing a doctor about this problem as persisting problem, which he believes may be hypersensitivity/autoimmune vasculitis caused by the reaction to the shot. It has been 2 months and I still have lasting symptoms. My ankles continue to swell and red dots will reappear.
A report received from a consumer on 11/04/02, concerning a 55 year old female vaccinee who experienced pain, redness, swelling and warmth at the injection site a few hours after receiving the Fluvirin vaccine in the upper arm on 10/29/02. On 10/29/02, the vaccinee experienced severe pain, redness, swelling and warmth at the injection site which worsened for a few days. On 11/1/02, the vaccinee was seen by a dermatologist for a routine examination and was advised to place ice packs on the affected area. The vaccinee did not take any medication to relieve the symptoms. At the time of this report the symptoms are alleviated and tolerable but not completely resolved. The vaccinee has previously received influenza injections (brand unspecified) for many years without any problems.
This patient was seen on 08/02/01 for a well child visit. Vaccinations given MMR, Varivax, Prevnar, and Hep B # 3. 10 days later this patient developed a fever and a morbilliform rash on her face and upper arm.
Pt recvd vax & 5 days post vax pt exp redness & itching below inject site (size of grapefruit); pt is obese & swelling appeared to be minimal; No treatment initiated; timing of last immun is unk;
Within a week post vax, the pt developed muscle stiffness, knee pain and swelling in both hands. Pt was treated with high dose steroids, followed by low dose steroids and Plaquinal. From follow-up info received on 10/25/00, it was reported that the pt recovered. Follow-up info received on 5/7/01, it was reported, consultation of Rheumatologist on 4/2/01, dx: Serologically negative inflammatory arthritis.
I contracted COVID-19 on 11/28/22 with symptoms of sore throat, head congestion, chest congestion, cough, severe headache, sneezing, fatigue, diarrhea, and low-grade fever. I was prescribed, PAXLOVID, prednisone, and azithromycin on 09/29/22. I experienced rebound illness beginning on 12/06/22. My symptoms began to abate again after 12/10/22, but my symptoms have not fully resolved yet. I am still experiencing headache, head congestion, cough and fatigue; I am taking TYLENOL/codeine and SUDAFED manage my symptoms.
DX; Chicken pox (varicella Zoster). Sx; spots on chest and legs (06/03/2005) Varicellaform rash. TX; supportive.
It has lasted so long and gotten worse after the second shot.; not feeling well; This is a spontaneous report from a contactable consumer (patient).  A 71-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 2 via an unspecified route of administration, in Arm Left on 23Mar2021 (Batch/Lot number was not reported) as single dose for covid-19 immunisation and pregabalin (LYRICA), via an unspecified route of administration from an unspecified date (Batch/Lot number was not reported) to an unspecified date, at 300 mg for neuropathy peripheral.  Medical history included neuropathy peripheral. Patient received the first vaccination dose on 02Mar2021. There were no concomitant medications.  The patient started not feeling well on 25Mar2021. It has lasted so long and gotten worse after the second shot.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
This spontaneous report as received from a pharmacist refers to a 50 year old female patient. On 09-OCT-2013 the patient was vaccinated with ZOSTAVAX vial (subcutaneous, dosage unknown, lot # J004267 exp 12-JUL-2014). On 10-OCT-2013, the patient reported a silver dollar size rash around injection site, which is painful, swollen, tender and warm to the touch. The patient sought for medical attention (called pharmacy). No lab diagnostics studies were performed. The outcome of the events was reported as recovering. Additional information has been requested.
I have had clotty periods since my first dose of the vaccine and it isn?t stopping. It isn?t as heavy as usual but it?s a constant period that doesn?t go away even with taking birth control.
"Patient here for Moderna booster vaccine. After 10 min of waiting on lobby. Pt c/o to receptionist not feeling well dizziness. Provider was called for evaluation.   Per patient has been having a stressful day with doctors apt and court apt's. Had a Burrito to eat in AM. Pt states has been using insulin and taking her Metformin.       Blood sugar check at the time of evaluation  530 RBS   Blood sugar- 453 at 2:39    Pt stated she was feeling well and not feeling dizzy no more. Per Provider pt was Ok to leave to her apt with social Navigator at Hospital.    Prior to immunization Pt has an apt scheduled for: Future Appointments Date Time Provider Department Center 5/11/2022  3:00 PM  5/12/2022  2:20 PM   - RN completing this form was not present during event but is entering for the mobile team.   Provider allowed patient to leave and reminded her of importance that she go to clinic the next day with provider.
chills/ shivering; headache; This case was reported by a consumer via call center representative and described the occurrence of chills in a 66-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 3rd June 2019, the patient received the 2nd dose of Shingrix. On 3rd June 2019, several hours after receiving Shingrix, the patient experienced chills and headache. The patient was treated with acetylsalicylic acid (Aspirin). On an unknown date, the outcome of the chills was recovering/resolving and the outcome of the headache was not recovered/not resolved.   It was unknown if the reporter considered the chills and headache to be related to Shingrix.  Additional details were provided as follows: This case was reported by the patient herself. The patient received 2nd dose of Shingrix, on the day before reporting in afternoon. Last night of reporting date, several hours after vaccination, the patient experienced chills/ shivering and less than a week after vaccination, the patient experienced headache. The patient was feeling better for chills/ shivering, but was still having headache. The patient received treatment with couple of Aspirin for headache and enquiring if there was something better than that.
PERIPHERAL NEUROPATHY ACUTE HYPOXEMIC RESPIRATORY FAILURE 12/7/2021, 1/5/2022,  1/8/2022,  4/9/2022,  12/16/2022 -- RECURRENCE OF SAME SYMPTOMS
Two weeks after I had a huge blood red rash and hives that burned and it went from injection site down to the elbow.
FLUBLOK GIVEN TO PATIENT WHOS IS UNDER 18 YEARS OLD
BLOOD SQUIRTED; LUMP AT INJECTION SITE; This spontaneous report received from a pharmacist concerned a unknown age, race, and ethnic origin.  The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown, expiry: unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, the patient experienced blood squirted, and lump at injection site. The HCP was informed these events had to be reported, but did not want to report them. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the blood squirted and lump at injection site was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0:20210709552-covid-19 vaccine ad26.cov2.s-blood squirted. This event(s) is considered unassessable. The event(s) has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
This case was reported by a healthcare professional (nurse) via Merck and described the occurrence of fever in an unspecified number of subjects of unspecified ages and gender who were vaccinated with PEDIARIX (GlaxoSmithKline), DTPA. On an unspecified dates the subjects received unspecified doses of PEDIARIX (unknown) or unspecified doses of DTPA (unknown). At unspecified times after vaccination with DTPA or PEDIARIX, the subjects experienced fever. A nurse mentioned that some subject developed a fever after receiving PEDIARIX and TDAP vaccines. At the time of the report no other information was provided. At the time of reporting the outcome of the fever was unspecified. The nurse's contact information was not provided, therefore no additional information could be obtained. PEDIARIX, the subjects experienced fever. A nurse mentioned that some subject develop a fever after receiving PEDIARIX and TDAP vaccines. At the time of the report no other information was provided. At the time of reporting the outcome of the fever was unspecified. The nurse's contact information was not provided, therefore no additional information could be obtained.
Stomach cramps, Itchy throat, neck itchy, and generalized warmth sensation without fever.
Arm ached evening of shot, followed by throbbing over the weekend with fever noted below shot area Sunday eve followed by swelling and redness and hot to touch Monday morning.
I received the vaccine in my left upper arm on Friday at 3:15pm. The site of injection  became red and swollen after a few hours and lasted for 4 days. About 24 hours after the injection, I had swelling in my underarm area on the left side.  Sunday evening at 11pm, I began to have chills and feel feverish, and that lasted until Monday around 2pm. Also overnight on Sunday, I developed pain in my left breast such that I could not lay on either side or allow anything to brush up against it. By the morning, it was swollen and red, and very painful. I am a nursing mother, and I also was not able to pump as much as was normal on that side at that time. I could feel a blockage. I called the nurse line at my gynecologist office, and I was told to monitor at home and call back if it gets worse. I followed all guidance to clear a blocked milk duct, and by Thursday morning, the pain had subsided and the blockage was clear. The swelling had also subsided, and my injection site was back to normal.
Patient received two doses of Flucelvax vaccine at 4:30 10/27/2023. No adverse event was observed.
A report has been received from a Health Professional concerning a 2 year old, Female subject, who had been receiving Nasal FLUMIST.  FLUMIST started on 11-JAN-2013. The reporter stated that expired FLUMIST was administered to the patient which started on 11-JAN-2013. The outcome of the event of EXPIRED FLUMIST ADMINISTERED is unknown. The report was concerning to be non-serious.